Introduction {#s1}
============

Multiple-breath inert gas washout (MBW) tests are used to assess uniformity of ventilation distribution in infants, children, and adults [@pone.0036083-Robinson1]. Both global indices of ventilation inhomogeneity such as the lung clearance index (LCI) and specific indices of non-uniform gas mixing in the *conducting* and *acinar* airway zones (S~cond~ and S~acin~) are frequently reported [@pone.0036083-Aurora1]--[@pone.0036083-Hall1]. The accuracy of these indices relies directly or indirectly on correctly measured functional residual capacity (FRC). Therefore current guidelines for lung function testing recommend *in vitro* FRC measurements over the full range of lung volumes in question at various respiratory frequencies [@pone.0036083-Frey1], [@pone.0036083-Wanger1].

FRC measurement validation is commonly assessed using calibration syringes to simulate FRC and tidal breathing washout [@pone.0036083-Horsley1]. However, *in vivo* accuracy of FRC measurements depends on the individual performance under physiological conditions of the gas and flow sensors used, ignored by the syringe. Given the increasing interest in MBW as a clinical outcome measure there is an urgent need for improved validation models which incorporate conditions encountered during clinical testing (*i.e.* variations in temperature, pressure and humidity over the breath cycle).

This report describes (i) the development and utility of a lung model incorporating simulated body temperature, pressure and water vapor saturation (BTPS) conditions, and (ii) the *in vitro* and *in vivo* performance of a commercial N~2~MBW system (Exhalyzer D®, Eco Medics AG, Duernten, Switzerland). Primary outcome was the accuracy and precision with which FRC can be generated and measured *in vitro* and the reproducibility of FRC *in vivo* in healthy adults. Secondary outcomes were the reproducibility of ventilation inhomogeneity indices and their correlation in healthy adults.

Methods {#s2}
=======

Nitrogen multiple-breath washout setup {#s2a}
--------------------------------------

We used an unmodified open-circuit N~2~MBW hardware and software package (Exhalyzer D® and Spiroware® 3.1, Eco Medics AG) for all recordings, and an in-house customized software based on TestPoint™ (Capital Equipment Corp, Billerica, MA, USA) for off-line data processing and analyses. Flow was measured using a mainstream ultrasonic flowmeter and used to derive tidal volumes [@pone.0036083-Latzin1]. Gas concentrations were measured by a side-stream laser O~2~ sensor (Oxigraf, Inc, Mountain View, CA, USA) and a main-stream infra-red CO~2~ sensor (Capnostat® 5, Respironics Novametrix LLC, Wallingford, CT, USA). In this device, F~N2~ is measured indirectly based on *Dalton*\'s law of partial pressures: F~N2~ = 1−F~O2~−F~CO2~−F~Argon~ (F~Argon~ = F~N2~ \* 0.00934/0.78084). The F~Argon~ (0.00934) is treated as a fixed proportion of the F~N2~ assuming similar washout during N~2~MBW. Daily two-point calibration and verification of the flow and O~2~ sensors, and zero calibration of the CO~2~ sensor were performed. The O~2~ sensor has a slower 10--90% response time (140 ms) than the CO~2~ sensor (55 ms). To align their signals, a speeding algorithm was applied to the O~2~ signal reducing its response to approximately 110 ms [@pone.0036083-Farmery1], [@pone.0036083-Arieli1]. Gas signals were synchronized to the flow signal using the re-inspired post-capillary dead space to produce a step response in CO~2~ and O~2~. The gas signal vectors were time shifted to the point in time when the post-capillary dead space had been inhaled such that a 50% change in gas signal deflection then occurred. This was repeated over a minimum of ten washout breaths and median "delay times" for CO~2~ (50 ms) and O~2~ (565 ms) were used for signal alignment. Quality of superimposition of the inverted O~2~ signal on the CO~2~ signal was assessed visually.

Lung (model) resident F~N2~ was washed out using 100% O~2~ applied via open circuit at either 200 mL/s for 100--400 mL FRCs or at 1000 mL/s for 500--4200 mL FRCs and *in vivo*, respectively ([Figure 1](#pone-0036083-g001){ref-type="fig"}). These bypass flows were chosen to exceed maximum tidal inspiratory flows and to minimize rebreathing of CO~2~ or N~2~. For respective lung volumes ([Table 1](#pone-0036083-t001){ref-type="table"}) we used post-capillary dead space reducers (infant set 1, preschool set 2, adult set 3) and hygienic inserts (Spirette) provided by the manufacturer (Eco Medics AG). These reduced equipment related post-capillary dead space (volume between CO~2~/O~2~ sampling point and bypass) to 1.5 mL, 16 mL, and 26.9 mL, respectively, as measured by water displacement. Bacteria filters (air eco slimline, Vickers Ind Est, LA, UK) had 30 mL dead space and were used for preschool and adult sets. Accordingly, pre-capillary dead space (volume between lung compartment top and CO~2~/O~2~ sampling point) was 37.9 mL in the large model and 3 mL in the small model, respectively. Apparatus resistance was measured by a pressure transducer (Timeter RT200, Allied Healthcare Products Inc., MO, USA). We applied pure O~2~ and increased flows stepwise between 0--200 mL/s for the infant set, 0--500 mL/s for the preschool set, and 0--770 mL/s for the adult set with bacteria filters in place. Maximum resistances were 0.03, 0.06, and 0.19 kPa/L\*s, respectively, and complied with the recommendations of previous standards [@pone.0036083-Wanger1], [@pone.0036083-Frey2].

![Schematic drawing of the lung model.\
The lung and ventilation compartments are partly filled with distilled water, their volumes are 6.94 L and 11.72 L, respectively. The outer chamber\'s volume is 67.73 L, filled with distilled water and constantly heated to 37°C. The dashed line reflects the water level determining tidal volume and functional residual capacity (FRC) at in- and expiratory end-tidal levels. FRC is the volume of air contained in the model at end-tidal expiration. One mm on the tape measure corresponds to 18.7 mL volume. FRC range is 0.5--4.2 L. O~2~ = sampling point of the side-stream oxygen sensor. CO~2~ = sampling point of the main-stream carbon dioxide sensor. Flowhead = main-stream ultrasonic flowmeter.](pone.0036083.g001){#pone-0036083-g001}
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###### Study protocol for the lung model.

![](pone.0036083.t001){#pone-0036083-t001-1}

  Lung model    DSR   Trial (n)    FRC (mL)    V~T~ (mL)   RR (min^−1^)
  ------------ ----- ----------- ------------ ----------- --------------
  Small          1        7        100--400     30--80        20--35
  Large          2       10       500--2000    150--540       12--29
  Large          3       33       2000--4200   190--880       10--29

Functional residual capacity (FRC), tidal volume (V~T~), and respiratory rate (RR) generated in triplets are displayed as ranges. Respective dead space reducers (DSR 1--3) were applied to reduce post-capillary dead space to 1.5 mL, 16 mL, and 26.9 mL, respectively. Mean (range) intra-test coefficient of variation (CV) of generated nominal FRCs was 0.1 (0.0--1.8)%.

The lung model {#s2b}
--------------

The framework of the lung model was constructed from acrylic glass (Soloplex, Tidaholm, Sweden) and consisted of two rigid chambers: An inner chamber divided into two communicating compartments (via their lower aspect) termed the lung and the ventilation compartment, and an outer chamber ([Figure 1](#pone-0036083-g001){ref-type="fig"}). Two different size models were constructed to allow for both infant (100 to 400 mL) and children/adult (500 to 4200 mL) lung model volumes. The inner chamber was filled with distilled water until the desired FRC was achieved, measured as the end-expiratory water level using a transparent vertical tape measure fixed to the lung compartment. FRC volume was determined geometrically from known dimensions: one millimeter corresponded to 18.7 mL in the large and to 4.8 mL in the small lung model. The lung model was placed inside a water tank which served to heat the water in the inner chamber to 37°C, monitored using a thermostat. To simulate various breathing patterns, a bi-level positive airway pressure ventilator (Vivo 30, Breas Medical AB, Mölnlycke, Sweden) for the large lung model, or a 100 mL calibration syringe (Hans Rudolph Inc, Shawnee, KS, USA) for the small lung model was connected to the top of the ventilation compartment and exerted hydraulic pressure transmitted through to the lung compartment. During ventilation, temperature and humidity were measured every third FRC trial inside the lung compartment using a thermocouple thermometer (BAT-12 Microprobe Thermometer, Physitemp Instruments, Inc. New Jersey, USA) and a monolithic humidity sensor (HIH-4602-L-CP, linear humidity sensor, Honeywell, Minneapolis, USA).

*In vitro* study {#s2c}
----------------

Static signal linearity of the N~2~MBW system was assessed over the full range of O~2~, CO~2~, and N~2~ fractions encountered during N~2~MBW testing and performed at 37°C with 100% relative humidity: By increasing F~O2~ stepwise (60 steps), F~O2~ ranged from 15--100%, F~CO2~ from 0--6%, and F~N2~ from 0--79%. The reference for measured gas concentrations was a respiratory mass spectrometer (AMIS 2000; Innovision A/S, Odense, Denmark).

*In vitro* assessments of the N~2~MBW system performance were undertaken as triplicate FRC measurements (n = 150) across 50 different nominal FRCs (100 to 4200 mL), over two days. Ventilator pressures in the large model or syringe stroke volumes in the small volume were chosen to achieve physiological tidal volumes (V~T~), V~T~ over FRC ratios (V~T~/FRC), and respiratory rates (RR) for each FRC setting ([Table 1](#pone-0036083-t001){ref-type="table"}). To assess the possible influence of different F~CO2~ on FRC measurement accuracy, the lung compartment was washed-in with either ambient air (0.05% CO~2~) or CO~2~ enriched air (n = 45, Carboair®, Aiolos Medical, Karlstad, Sweden) prior to N~2~MBW. Carboair® contains 5% CO~2~ and balance air.

*In vivo* study {#s2d}
---------------

Thirty-two healthy adults performed N~2~MBW on two test occasions within a three week period. All subjects had a standardized interview on respiratory health. Inclusion criteria were adults aged 19 to 70 years with a smoking history less than five pack-years, no history of acute or chronic airway disease, and no on-going medication potentially affecting lung function. N~2~MBW was performed in the sitting position using a nose clip with the dead space reducer (set 3), hygienic insert, and bacterial filter in place. N~2~MBW was done in triplets with between-test intervals exceeding the washout time. The subjects were instructed to breathe regularly with relaxed expirations. The washout phase was terminated once end-tidal F~N2~ was less than 1/40^th^ of the starting F~N2~ for at least three breaths.

Ethics statement {#s2e}
----------------

The *in vivo* study was approved by the Ethics Committee of the University of Gothenburg Sweden. We obtained informed consent from all participants involved in the study.

Nitrogen multiple-breath washout outcomes {#s2f}
-----------------------------------------

FRC was calculated as *net* expired N~2~ volume (expired N~2~ volume minus re-inspired N~2~ volume) divided by the difference of F~N2~ at start of MBW minus F~N2~ at end of MBW. Pre-capillary dead space was subtracted from FRC such that the reported FRC corresponds to the volume of the inner compartment of the lung model or FRC at the airway opening in the *in vivo* recordings. Indices of ventilation inhomogeneity were calculated from *in vivo* N~2~MBW trials. Because LCI, S~acin~, and S~cond~ relate inversely to ventilation efficiency, their values increase with increasing ventilation inhomogeneity. LCI was calculated as cumulative expired gas volume (CEV) required to reduce F~N2~ to 1/40^th^ of the starting F~N2~, divided by FRC. Two phase III slope (S~III~) indices, S~cond~ and S~acin~, were calculated. Automated S~III~ fitting over 50--95% of expired volume was performed for each breath and manually adjusted to exclude phase II or IV from the linear regression fit. S~III~ was normalized (Sn~III~) by dividing S~III~ by the mean F~N2~ over S~III~ and multiplying S~III~ with V~T~, and averaged per breath from the three N~2~MBWs [@pone.0036083-Green1]. Mean Sn~III~ per breath was then plotted against the corresponding mean lung volume turnover (TO = CEV/FRC) for each breath. S~cond~ is defined as the rate of Sn~III~ increase between lung volume turnovers 1.5 and 6.0. S~acin~ is defined as the first breath Sn~III~ value minus the convection-dependent inhomogeneity contribution to this value [@pone.0036083-Verbanck3].

Statistics {#s2g}
----------

Linearity of sensors compared to mass spectrometry was assessed using uni-variable linear regression and respective signal offsets (linear model intercept) and gains (linear model slope) with their 95% confidence intervals (CI) were reported. Intra-test variability of both model and measured FRCs as generated by the model and measured by the N~2~MBW setup, respectively, was calculated as intra-test coefficient of variation (CV = SD/mean\*100). Accuracy of FRC measurements was expressed as (i) absolute (mL) difference (difference between measured FRC minus model FRC), (ii) relative (%) difference (difference\*100 divided by model FRC), and as (iii) relative error (square-root of the squared relative difference). Acceptable upper limit was 5% error according to current infant lung function standards [@pone.0036083-Frey1]. We reported coefficient of repeatability (CR) calculated as 1.96\*SD of differences between paired measurements [@pone.0036083-Bland1]. The CR estimates the 95% range of technical variability due to measurement error *in vitro* or the technical and physiological between-test variability *in vivo*. We assessed *Bland Altman* plots [@pone.0036083-Bland1], and the relation of error with FRC, breathing pattern, different lung model gases, and between tests using uni- and multi-variable linear regression models and paired *t*-tests. P-values\<0.05 were considered statistically significant and all analyses were done using Stata™ (Stata Statistical Software: Release 11. College Station, TX: StataCorp LP).

Results {#s3}
=======

Lung model performance {#s3a}
----------------------

The lung model successfully generated 146 (97%) out of 150 FRCs (range 100--4174 mL) under BTPS conditions. Mean (SD) of temperature and humidity were 35.9 (1.3)°C and 97.9 (1.0)%, respectively, obtained from 18 measurements. Following water refilling, four gas temperature drops of 3°C were observed and respective FRC recordings were subsequently excluded. Realistic breathing patterns were applied with V~T~ between 30 and 877 mL, V~T~/FRC between 0.14 and 0.55, and RR between 10 and 35 min^−1^. The intra-test variability of FRCs generated by the lung models was low overall, CV mean (SD) was 0.07 (0.31)%, and lower in the large model compared to the small model: CV mean (SD) was 0.03 (0.15)% and 0.23 (0.64)%, p = 0.108, respectively. The potential parallax error of reading water levels using the tape measure was estimated as one mm corresponding to 18.7 mL and 4.8 mL in the large and small lung model, respectively. Relating these volumes to the nominal FRC, the relative mean (range) parallax error was 1.2 (0.4--3.7)% and 2.9 (1.2--4.8)% in the large lung and small model, respectively.

*In vitro* performance of the nitrogen multiple-breath washout setup {#s3b}
--------------------------------------------------------------------

The O~2~, CO~2~, and N~2~ signals were linear over the full range. R^2^ was \>0.99 for all signals ([Table 2](#pone-0036083-t002){ref-type="table"}). The N~2~MBW setup accurately measured FRC with low intra-test variability ([Figure 2](#pone-0036083-g002){ref-type="fig"}, [Table 3](#pone-0036083-t003){ref-type="table"}). Of 146 FRC measurements one measurement was excluded due to incomplete N~2~ washout. In 48 triplicate FRC measurements, mean (SD) of CV was 1.4 (1.7)%. Absolute mean (SD) difference between measured and model FRC was 9.2 (52.3) mL, relative difference was −0.2 (2.9)%. Of 145 FRCs measured between 100 mL and 4200 mL, 130 (90%) FRC measurements were within the 5% of model FRCs ([Figures 2](#pone-0036083-g002){ref-type="fig"}, [3](#pone-0036083-g003){ref-type="fig"}). Mean (SD) error was 2.3 (1.7)% in all measurements. In the large lung model (500 to 4174 mL FRCs), 121/124 (98%) of FRCs were within the 5% error limit, error range was 0.0--6.5%. In the small lung model (100 to 400 mL FRCs), 9 (43%) out of 21 FRCs were within the 5% error limit, error range was 1.0--7.1%.

![*In vitro* variability of functional residual capacity measurement.\
*Bland Altman* plot [@pone.0036083-Bland1] of measured functional residual capacity (FRC) minus lung model FRC plotted vs. mean of measured and model FRC. Differences (open circles), and mean difference, and upper and lower limits of agreement (mean difference ±1.96 SD of differences) are given as dashed lines for the small lung model and as solid lines for the large lung model. [Figure 2a](#pone-0036083-g002){ref-type="fig"} gives absolute FRC differences (mL). For the small and large lung model, mean differences are −10.2 mL and 12.5 mL, upper limits of agreement are 9.9 mL and 121.9 mL, and lower limits of agreement are −30.3 mL and −96.8 mL, respectively. [Figure 2b](#pone-0036083-g002){ref-type="fig"} gives relative FRC differences (%). For the small and large lung model, mean differences are −3.8% and 0.4%, upper limits of agreement are 3.6% and 4.7%, and lower limits of agreements are −11.2% and −4.0%, respectively.](pone.0036083.g002){#pone-0036083-g002}

![Association of measurement error with lung volume.\
Functional residual capacity (FRC) measurement error (%) is plotted against lung model FRC. The error data are displayed as open circles for the small model (100--400 mL FRCs) and closed circles for the large model (500--4200 mL FRCs). The dashed line gives the 5% limit of acceptable measurement error, the dotted lines reflect possible nominal volume bias due to reading parallax error (one mm) in the small and large lung model.](pone.0036083.g003){#pone-0036083-g003}

10.1371/journal.pone.0036083.t002

###### Linearity of sensors.

![](pone.0036083.t002){#pone-0036083-t002-2}

                            Offset        Gain                             
  ------------------------ -------- ---------------- ------ -------------- --------
  **Oxygen** (%)            −0.47    −0.79 to −0.15   1.01   1.00 to 1.01   \>0.99
  **Carbon dioxide** (%)    −0.05    −0.12 to 0.02    1.08   1.06 to 1.10   \>0.99
  **Nitrogen** (%)           0.09    −0.17 to 0.35    0.99   0.98 to 1.00   \>0.99

Oxygen and carbon dioxide and the derived nitrogen signals from the nitrogen multiple-breath washout setup were compared to mass spectrometer signals (AMIS 2000). Linear regression derived intercept (model offset), model slope (model gain) with respective 95% confidence intervals (CI), and R-squared (R^2^) are given.

10.1371/journal.pone.0036083.t003

###### Nitrogen multiple-breath washout outcomes and variability.

![](pone.0036083.t003){#pone-0036083-t003-3}

  *In vitro* nitrogen multiple-breath washout outcomes                                                                  
  ------------------------------------------------------ ----------------- ----------- --------------------- ---------- ------
  **FRC^\*^** (mL)                                         207.5 (107.0)    2.7 (2.0)   −10.2 (−5.5; −14.9)   20.1 mL    9.7%
  **FRC^†^** (mL)                                         2360.0 (1186.1)   1.0 (1.4)    12.5 (2.6; 22.5)     109.3 mL   4.6%

  *In vivo* nitrogen multiple-breath washout outcomes                                                                   
  ----------------------------------------------------- ---------------- ----------- ----------------------- ---------- -------
  **FRC^‡^** (mL)                                        3249.6 (728.3)   4.5 (3.2)   −15.4 (−169.5; 138.7)   808.7 mL   24.9%
  **LCI**                                                 7.19 (0.53)     3.2 (1.7)    −0.13 (−0.26; 0.00)      0.68     9.5%
  **S~acin~**                                            0.063 (0.029)      n.a.      0.001 (−0.005; 0.007)    0.031     49.2%
  **S~cond~**                                            0.019 (0.005)      n.a.      0.000 (−0.002; 0.001)    0.008     41.4%

Triplicate nitrogen multiple-breath washout (N~2~MBW) tests applied to measure functional residual capacity (FRC) *in vitro* in the small^\*^ (n = 7) and the large^†^ lung model (n = 41), and in 30 healthy adults^‡^. LCI = lung clearance index. S~acin~ = phase III slope index of *acinar* ventilation inhomogeneity. S~cond~ = phase III slope index of conductive ventilation inhomogeneity. CV = intra-test coefficient of variation (SD/mean\*100). Mean difference^§^ (95% confidence interval) from paired *t*-tests comparing measured and actual model FRC \[*in vitro*\] or N~2~MBW outcomes between two test occasions \[*in vivo*\]. CR = coefficient of repeatability (1.96\*SD of differences between measured and actual model FRC or differences of N~2~MBW outcomes between tests). CR is given in respective units or as percentage of the mean. n.a. = not applicable.

Errors in FRC measurements in lung models containing either ambient or CO~2~ enriched air were similar. Comparing the mean (SD) error using ambient air (n = 102) *vs.* CO~2~ enriched air (n = 43), the mean (SD) error was 2.2 (1.7)% *vs.* 2.6 (1.8)%, p = 0.185. Errors in FRCs measurements recorded on day one (n = 72) *vs.* day two (n = 73) differed, mean (SD) error 1.6 (1.0)% *vs.* 2.1 (1.4)%, p = 0.024. There was a positive association between error and RR (R^2^ = 0.24, p\<0.001), and negative associations with V~T~ (R^2^ = 0.16, p\<0.001), mean expiratory flow (R^2^ = 0.15, p\<0.001), measurement duration (R^2^ = 0.12, p\<0.001), and FRC (R^2^ = 0.09, p\<0.001). Accounting for RR in a multi-variable regression model, the association of error with mean expiratory flow remained significant (p = 0.036) but not with V~T~, measurement duration, or FRC.

*In vivo* performance of the nitrogen multiple-breath washout setup {#s3c}
-------------------------------------------------------------------

Thirty out of 32 healthy adults (15 females) successfully performed N~2~MBW on two test occasions with a mean (SD) of 12.2 (5.1) days in between. Mean (range) age was 49.3 (21--69) years. Two males did not achieve leak-free N~2~MBW. All subjects had normal spirometry indices. Mean (SD) z-scores [@pone.0036083-Stanojevic1] of forced expiratory volume in one second (FEV~1~), FEV~1~/forced vital capacity, and forced expiratory flow between 25--75% of expired volume (FEF~25--75~) were 0.75 (0.86), 0.24 (0.81), and 0.32 (0.82), respectively.

*In vivo* FRC intra-test variability was greater than measured in model FRC: CV mean (SD) was 4.5 (3.2)% *vs.* 1.4 (1.7)%, p\<0.001. Likewise the *in vivo* FRC error between tests was greater compared to the *in vitro* FRC error measured in the models: Error mean (SD) was 10.1 (8.2)% *vs.* 2.3 (1.7)%, p\<0.001. Reproducibility of ventilation inhomogeneity indices differed significantly with the LCI representing the most reproducible index ([Table 3](#pone-0036083-t003){ref-type="table"}). *In vivo* reproducibility for LCI was better than for FRC, and markedly better than for S~acin~ and S~cond~ ([Figures 4](#pone-0036083-g004){ref-type="fig"}, [5](#pone-0036083-g005){ref-type="fig"}). LCI was correlated with S~acin~ (*Pearson* r = 0.61, p\<0.001) but not with S~cond~ (r = 0.17, p = 0.377). S~acin~ was correlated with S~cond~ (r = 0.44, p = 0.016). Estimates of repeatability (CV) and reproducibility (CR) of FRC and ventilation inhomogeneity indices were not associated with number of days between tests or the subject\'s age and gender (data not shown).

![*In vivo* variability of functional residual capacity.\
*Bland Altman* plot [@pone.0036083-Bland1] of functional residual capacity (FRC) measured on two study days within three weeks in 30 healthy adults. Absolute FRC differences ([Figure 4a](#pone-0036083-g004){ref-type="fig"}), relative FRC differences ([Figure 4b](#pone-0036083-g004){ref-type="fig"}), mean difference and upper and lower limits of agreement (lines) are plotted against mean FRC of both tests. Mean difference is −15.4 mL (−1.1%), upper and lower limits of agreement are 793.3 mL (23.2%) and −824.1 mL (−25.4%).](pone.0036083.g004){#pone-0036083-g004}

![*In vivo* variability of lung clearance index.\
*Bland Altman* plot [@pone.0036083-Bland1] of lung clearance index (LCI) measured on two study days within three weeks in 30 healthy adults. Absolute LCI differences ([Figure 5a](#pone-0036083-g005){ref-type="fig"}), relative LCI differences ([Figure 5b](#pone-0036083-g005){ref-type="fig"}), mean difference and upper and lower limits of agreement (lines) are plotted against mean LCI of both study days. Mean difference is −0.13 (−1.8%), upper and lower limits of agreement are 0.55 (7.6%) and −0.81 (−11.2%).](pone.0036083.g005){#pone-0036083-g005}

Discussion {#s4}
==========

Summary {#s4a}
-------

This is the first study demonstrating that an available N~2~MBW system accurately and reliably measures FRC over the wide range of lung volumes and different breathing patterns encountered from early childhood to adulthood. This study also shows that BTPS conditions can be implemented into lung model studies to bench-test MBW equipment under realistic conditions. *In vitro* FRC can be measured with only 5% error over FRC volumes between 600 and 4200 mL with the N~2~MBW system. In FRCs below 600 mL, the error is better than 7%. N~2~MBW measurements in healthy adults show that LCI is more reproducible than FRC, S~acin~, and S~cond~. Variability of FRC measured *in vivo* is higher than *in vitro* suggesting substantial physiological fluctuation of FRC in humans [@pone.0036083-Hlastala1].

Comparison to previous lung model studies {#s4b}
-----------------------------------------

Data on quality of signals and their integration under realistic conditions are essential for appropriate evaluation of MBW setups [@pone.0036083-Robinson2]. As an initial step, linearity of O~2~, CO~2~, and N~2~ signals was confirmed over the full measurement range in heated humid conditions encountered during clinical N~2~MBW testing. We improved a lung model described by *Brunner et al.* [@pone.0036083-Brunner1], which was originally ventilated manually and the water contained within the model was not heated. In addition to the incorporation of BTPS conditions, physiological breathing patterns were applied. These conditions recreate the stress the system is exposed to during clinical testing across wide age ranges. Previous *in vitro* lung models lacked one or more important physiological aspects [@pone.0036083-Wauer1]--[@pone.0036083-Schibler2].

The current N~2~MBW system precisely measures lung volumes between 600 and 4200 mL. In this volume range approximating late preschool age to large sized adults, the *in vitro* measurement error was below 5% in all FRCs ([Figure 3](#pone-0036083-g003){ref-type="fig"}). Importantly, this N~2~MBW system is not susceptible to different F~CO2~. Indirect N~2~ measurement may be susceptible to drift in F~CO2~ as the current N~2~ signal or, *e.g.* molar mass, are sum signals of gas fractions including the F~CO2~ [@pone.0036083-Singer1].

This study is able to disentangle technical from physiological aspects contributing to FRC variability. Comparing the *in vitro* CR of FRC (4.6%) with *in vivo* (24.9%), inherent physiological variability of FRC may explain 20.3% (or relatively 82%) of between-test variability in adults. Validation studies exclusively performed *in vivo* do not allow differentiation between technical and physiological variability [@pone.0036083-Schibler1], [@pone.0036083-Schibler3]. In infants, the FRC error between tests may exceed 20% [@pone.0036083-Fuchs1], [@pone.0036083-Pillow1].

Ventilation inhomogeneity indices {#s4c}
---------------------------------

The current N~2~MBW setup can be easily applied to measure ventilation inhomogeneity indices *in vivo*. These measures correlate as shown previously [@pone.0036083-Verbanck3], [@pone.0036083-Verbanck4]. LCI, in particular, had high repeatability and reproducibility in healthy adults. The specific indices of non-uniform gas mixing in the *conducting* and *acinar* airway zones (S~cond~ and S~acin~) were more variable. Between-test reproducibility of LCI (CR = 9.5%) was markedly higher than for S~acin~ (49.2%) and S~cond~ (41.4%). In a recent study [@pone.0036083-Downie1], comparable between-test reproducibility of LCI, S~acin~, and S~cond~ was reported in healthy adults performing a sulfur hexafluoride MBW protocol with tidal breathing restricted to one liter V~T~. The small technical error of FRC observed *in vitro* strongly suggests higher physiological variability of these Sn~III~ indices compared to volume indices (FRC, LCI). Sn~III~ depends on breathing pattern [@pone.0036083-Crawford1], which was not restricted in this study. Interestingly, LCI is even more reproducible than FRC as also shown in healthy children [@pone.0036083-Fuchs2]. This may reflect the fact that LCI is a robust volume ratio (CEV/FRC), cancelling the effect of physiological changes in lung volumes.

Limitations {#s4d}
-----------

While the large lung model was suited for the MBW bench test, the small model may require adjustments. Automated ventilation and a laser sensor for determining nominal FRC could improve the infant lung model. Parallax error in the large model was small enough to avoid over- or underestimation of nominal FRCs ([Figure 3](#pone-0036083-g003){ref-type="fig"}).

Within the small technical measurement error of FRC, RR and tidal flow were correlated with error. Whether this association was causal leading to signal asynchrony or rather a surrogate for flow-dependent temperature and humidity fluctuations hampering adequate BTPS correction remains to be determined [@pone.0036083-Latzin1]. We hypothesize that the apparatus dead space volumes behave as systems taking up and delivering heat energy and moisture non-linearly over breath cycles. Reduced dead space and dynamic BTPS and synchronization algorithms may further decrease measurement error.

The current and previous models did not allow assessment of "tissue" N~2~ contribution to the lung inherent F~N2~. This contribution is difficult to estimate and account for, as available data are limited [@pone.0036083-Lundin1]. In adults with more advanced lung disease, duration of N~2~MBW and bias from tissue N~2~ may increase, and intervals between tests should be adapted accordingly [@pone.0036083-Wanger1].

Implications {#s4e}
------------

Availability of realistic validation protocols will aid the transition of MBW from promising research tool into routine clinical use. This is the first validation of an available N~2~MBW setup using physiological *in vitro* test conditions. Many other MBW setups remain to be validated and are either customized, expensive, or have been taken off the market [@pone.0036083-Aurora1], [@pone.0036083-Gustafsson1], [@pone.0036083-Horsley1], [@pone.0036083-Kraemer1]. N~2~MBW is also advantageous to using foreign tracer gases because 100% O~2~ is economic, readily available in all hospitals, and non-polluting.

The between-test variability of ventilation inhomogeneity indices reported here sheds further light on their natural variability over time. The CR aids estimating clinically relevant change in lung function outcomes for future intervention studies. Given a hypothetical intervention in the current study, a decrease of LCI of 0.68 units (9.5%) would constitute a physiological change with 95% probability. Further longitudinal studies in disease groups, such as cystic fibrosis where variability is increased, are required [@pone.0036083-Amin1]--[@pone.0036083-Hall2]. In infants and preschool-aged children, safety of N~2~MBW and variability of N~2~MBW indices need to be determined.

Conclusion {#s4f}
----------

The performance of MBW setups can be realistically assessed using a new *in vitro* lung model producing BTPS conditions and representative breathing patterns. This lung model protocol is suitable for validation of other MBW systems. The new N~2~MBW system accurately and precisely measures lung volumes between 600 and 4200 mL. Future work may extend this into smaller lung volumes and younger age groups. The LCI represents the most reproducible N~2~MBW *in vivo* outcome as compared to FRC, S~cond~, and S~acin~. This study may aid the transition of this important type of lung function test from being a promising research tool to becoming a routine method in clinical practice.
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